Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis
Accumulating evidence points towards the antipsychotic potential of cannabidiol. However, the neurocognitive mechanisms underlying the antipsychotic effect of cannabidiol remain unclear. We investigated this in a double-blind, placebo-controlled, parallel-arm study. We investigated 33 antipsychotic-...
Saved in:
| Published in | Translational psychiatry Vol. 9; no. 1; pp. 203 - 10 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
22.08.2019
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Accumulating evidence points towards the antipsychotic potential of cannabidiol. However, the neurocognitive mechanisms underlying the antipsychotic effect of cannabidiol remain unclear. We investigated this in a double-blind, placebo-controlled, parallel-arm study. We investigated 33 antipsychotic-naïve subjects at clinical high risk for psychosis (CHR) randomised to 600 mg oral cannabidiol or placebo and compared them with 19 healthy controls. We used the monetary incentive delay task while participants underwent fMRI to study reward processing, known to be abnormal in psychosis. Reward and loss anticipation phases were combined to examine a motivational salience condition and compared with neutral condition. We observed abnormal activation in the left insula/parietal operculum in CHR participants given placebo compared to healthy controls associated with premature action initiation. Insular activation correlated with both positive psychotic symptoms and salience perception, as indexed by difference in reaction time between salient and neutral stimuli conditions. CBD attenuated the increased activation in the left insula/parietal operculum and was associated with overall slowing of reaction time, suggesting a possible mechanism for its putative antipsychotic effect by normalising motivational salience and moderating motor response. |
|---|---|
| AbstractList | Accumulating evidence points towards the antipsychotic potential of cannabidiol. However, the neurocognitive mechanisms underlying the antipsychotic effect of cannabidiol remain unclear. We investigated this in a double-blind, placebo-controlled, parallel-arm study. We investigated 33 antipsychotic-naïve subjects at clinical high risk for psychosis (CHR) randomised to 600 mg oral cannabidiol or placebo and compared them with 19 healthy controls. We used the monetary incentive delay task while participants underwent fMRI to study reward processing, known to be abnormal in psychosis. Reward and loss anticipation phases were combined to examine a motivational salience condition and compared with neutral condition. We observed abnormal activation in the left insula/parietal operculum in CHR participants given placebo compared to healthy controls associated with premature action initiation. Insular activation correlated with both positive psychotic symptoms and salience perception, as indexed by difference in reaction time between salient and neutral stimuli conditions. CBD attenuated the increased activation in the left insula/parietal operculum and was associated with overall slowing of reaction time, suggesting a possible mechanism for its putative antipsychotic effect by normalising motivational salience and moderating motor response. Accumulating evidence points towards the antipsychotic potential of cannabidiol. However, the neurocognitive mechanisms underlying the antipsychotic effect of cannabidiol remain unclear. We investigated this in a double-blind, placebo-controlled, parallel-arm study. We investigated 33 antipsychotic-naïve subjects at clinical high risk for psychosis (CHR) randomised to 600 mg oral cannabidiol or placebo and compared them with 19 healthy controls. We used the monetary incentive delay task while participants underwent fMRI to study reward processing, known to be abnormal in psychosis. Reward and loss anticipation phases were combined to examine a motivational salience condition and compared with neutral condition. We observed abnormal activation in the left insula/parietal operculum in CHR participants given placebo compared to healthy controls associated with premature action initiation. Insular activation correlated with both positive psychotic symptoms and salience perception, as indexed by difference in reaction time between salient and neutral stimuli conditions. CBD attenuated the increased activation in the left insula/parietal operculum and was associated with overall slowing of reaction time, suggesting a possible mechanism for its putative antipsychotic effect by normalising motivational salience and moderating motor response.Accumulating evidence points towards the antipsychotic potential of cannabidiol. However, the neurocognitive mechanisms underlying the antipsychotic effect of cannabidiol remain unclear. We investigated this in a double-blind, placebo-controlled, parallel-arm study. We investigated 33 antipsychotic-naïve subjects at clinical high risk for psychosis (CHR) randomised to 600 mg oral cannabidiol or placebo and compared them with 19 healthy controls. We used the monetary incentive delay task while participants underwent fMRI to study reward processing, known to be abnormal in psychosis. Reward and loss anticipation phases were combined to examine a motivational salience condition and compared with neutral condition. We observed abnormal activation in the left insula/parietal operculum in CHR participants given placebo compared to healthy controls associated with premature action initiation. Insular activation correlated with both positive psychotic symptoms and salience perception, as indexed by difference in reaction time between salient and neutral stimuli conditions. CBD attenuated the increased activation in the left insula/parietal operculum and was associated with overall slowing of reaction time, suggesting a possible mechanism for its putative antipsychotic effect by normalising motivational salience and moderating motor response. |
| ArticleNumber | 203 |
| Author | Wilson, Robin Petros, Natalia Perez, Jesus Appiah-Kusi, Elizabeth Allen, Paul McGuire, Philip Brammer, Michael Bhattacharyya, Sagnik Bossong, Matthijs G. |
| Author_xml | – sequence: 1 givenname: Robin surname: Wilson fullname: Wilson, Robin organization: Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London – sequence: 2 givenname: Matthijs G. surname: Bossong fullname: Bossong, Matthijs G. organization: Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht – sequence: 3 givenname: Elizabeth surname: Appiah-Kusi fullname: Appiah-Kusi, Elizabeth organization: Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London – sequence: 4 givenname: Natalia orcidid: 0000-0002-0802-0941 surname: Petros fullname: Petros, Natalia organization: Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London – sequence: 5 givenname: Michael surname: Brammer fullname: Brammer, Michael organization: Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, Centre for Neuroimaging Sciences, Department of Neuroimaging, Institute of Psychiatry, Psychology, and Neuroscience, King’s College London – sequence: 6 givenname: Jesus surname: Perez fullname: Perez, Jesus organization: CAMEO Early Intervention Service, Cambridgeshire and Peterborough NHS Foundation Trust – sequence: 7 givenname: Paul surname: Allen fullname: Allen, Paul organization: Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, Cognition, Neuroscience and Neuroimaging (CNNI) Laboratory, Department of Psychology, University of Roehampton – sequence: 8 givenname: Philip surname: McGuire fullname: McGuire, Philip organization: Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London – sequence: 9 givenname: Sagnik orcidid: 0000-0002-8688-8025 surname: Bhattacharyya fullname: Bhattacharyya, Sagnik email: sagnik.2.bhattacharyya@kcl.ac.uk organization: Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31439831$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk9vFCEYxompsbX2A3gxJF68jPJ3h7mYmI2tJk289E4YhtllZWHkZZrstZ9cxq21NlEukJff8-SF93mJTmKKDqHXlLynhKsPICjvVENo1xDJRcOeoTNGpWo4Verk0fkUXQDsSF1SKNrSF-iUU1G1nJ6hu7WJ0fR-8ClgU4qLsykOsI8wB5PxcIBxjrb4FPEwZx83eJ-KvzVLxQQMJngXrcNTTtYBLICPGOZ-52yBaolt8NHbym79Zouzh-94TBlPcLDbBB5eoeejCeAu7vdzdHP5-Wb9pbn-dvV1_em6saIlpRHMKuZ6Ltp-kJaPwlIuR-JU149930nrFJFslFIMUkq3sozRTvAVd9x0pufn6OPRdpr7vRusiyWboKfs9yYfdDJe_30T_VZv0q1etWTFW1EN3t0b5PRjdlD03oN1IZjo0gyaMUUpEZwv6Nsn6C7Nuf7XQrWKECoEqdSbxx09tPJ7OhWgR8DmBJDd-IBQopcQ6GMIdA2BXkKgWdW0TzTWl1_Tqo_y4b9KdlTCtMzZ5T9N_1v0E0pMySQ |
| CitedBy_id | crossref_primary_10_1016_j_amp_2023_02_011 crossref_primary_10_3928_00485713_20230505_01 crossref_primary_10_1055_a_2228_6118 crossref_primary_10_3389_fncel_2022_1010478 crossref_primary_10_3390_biom10111575 crossref_primary_10_1177_02698811221092506 crossref_primary_10_1016_j_tips_2024_12_005 crossref_primary_10_3389_fpsyt_2021_694394 crossref_primary_10_1186_s13034_024_00846_5 crossref_primary_10_1007_s00213_021_05801_2 crossref_primary_10_1186_s12916_022_02459_1 crossref_primary_10_1089_can_2021_0166 crossref_primary_10_1093_schizbullopen_sgab053 crossref_primary_10_3389_fphar_2020_635763 crossref_primary_10_3389_fpsyt_2023_1088459 crossref_primary_10_1017_S0033291722001672 crossref_primary_10_1038_s41537_021_00163_2 crossref_primary_10_1177_0706743719895195 crossref_primary_10_3389_fphar_2020_618184 crossref_primary_10_3389_fphar_2023_1328885 crossref_primary_10_1016_j_jpsychires_2024_05_029 crossref_primary_10_21661_r_554291 crossref_primary_10_1007_s40290_022_00446_8 crossref_primary_10_1016_j_conctc_2024_101341 crossref_primary_10_1038_s41380_024_02869_y crossref_primary_10_3390_life12122117 crossref_primary_10_1007_s40267_020_00781_3 crossref_primary_10_1038_s41398_020_0862_2 crossref_primary_10_1017_S0033291723002775 crossref_primary_10_2174_0122106766234102230919064455 crossref_primary_10_3390_ijms22041986 crossref_primary_10_3310_YNFH9826 crossref_primary_10_3389_fpsyg_2020_00833 crossref_primary_10_1093_ijnp_pyad009 crossref_primary_10_1016_j_scog_2021_100235 crossref_primary_10_1097_YCO_0000000000000596 crossref_primary_10_1093_schizbullopen_sgad022 crossref_primary_10_1186_s42238_024_00224_0 crossref_primary_10_3389_fpsyt_2020_00859 crossref_primary_10_1007_s00406_024_01794_z crossref_primary_10_3389_fpsyt_2022_992657 crossref_primary_10_1007_s00406_025_01983_4 crossref_primary_10_1038_s41380_021_01086_1 crossref_primary_10_1007_s00406_021_01318_z crossref_primary_10_1007_s00213_021_05905_9 crossref_primary_10_1016_j_jpsychires_2023_05_019 |
| Cites_doi | 10.1007/s00221-011-2583-5 10.1093/schbul/sbt161 10.1016/j.neuroimage.2013.04.052 10.1177/0269881112460109 10.1017/S0033291716001057 10.1016/j.tins.2014.12.005 10.1038/nrn3857 10.1176/appi.ajp.2017.17030325 10.1038/npp.2009.184 10.1016/j.neuron.2013.02.011 10.1073/pnas.0800005105 10.1111/bph.13250 10.1176/appi.ajp.2011.11010160 10.1016/j.biopsych.2008.05.032 10.1016/j.schres.2009.03.024 10.1016/j.biopsych.2015.08.021 10.1007/s00213-018-4885-9 10.1001/jamapsychiatry.2018.2309 10.1080/j.1440-1614.2005.01714.x 10.1007/s11065-018-9385-5 10.1093/schbul/sbt197 10.1016/j.schres.2008.12.029 10.1007/s00429-010-0262-0 10.1523/JNEUROSCI.2058-08.2008 10.1159/000337130 10.3389/fpsyt.2016.00189 10.1016/j.biopsych.2012.02.007 10.1016/j.schres.2007.02.012 10.1017/S0033291716001410 10.1038/tp.2017.174 10.1016/j.tins.2013.11.003 10.1093/schbul/sbs147 10.1523/JNEUROSCI.5587-06.2007 10.1016/j.schres.2015.04.036 10.1038/tp.2012.15 10.1006/nimg.2000.0593 10.1001/archgenpsychiatry.2012.169 10.1176/appi.ajp.2015.15040485 10.1017/S0033291716002439 10.1038/sj.bjp.0704327 10.1001/archgenpsychiatry.2012.847 10.1038/nrn.2015.26 10.1016/j.neubiorev.2012.07.012 10.1001/jamapsychiatry.2015.2196 10.1016/j.biopsych.2012.11.017 10.1016/j.biopsych.2012.04.020 10.3389/fnbeh.2014.00382 10.1176/appi.ajp.160.1.13 10.1093/schbul/sby094 10.1016/j.psym.2018.03.006 10.1503/jpn.100176 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2019 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2019 – notice: 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1038/s41398-019-0534-2 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Local Electronic Collection Information ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2158-3188 |
| EndPage | 10 |
| ExternalDocumentID | PMC6706374 31439831 10_1038_s41398_019_0534_2 |
| Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: DH | National Institute for Health Research (NIHR) grantid: NIHR CS-11-001 funderid: https://doi.org/10.13039/501100000272 – fundername: RCUK | Medical Research Council (MRC) grantid: CiC; MR/J012149/1 funderid: https://doi.org/10.13039/501100000265 – fundername: Medical Research Council grantid: MR/J012149/1 – fundername: RCUK | Medical Research Council (MRC) grantid: MR/J012149/1 – fundername: Department of Health grantid: EME/16/126/53 – fundername: ; grantid: NIHR CS-11-001 – fundername: ; grantid: CiC; MR/J012149/1 |
| GroupedDBID | --- 0R~ 3V. 53G 5VS 7X7 88E 8FI 8FJ AAJSJ AAKDD ABUWG ACGFO ACGFS ACMJI ACSMW ADBBV ADFRT AENEX AFKRA AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS BAWUL BCNDV BENPR BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EJD EMOBN FYUFA GROUPED_DOAJ GX1 HMCUK HYE KQ8 LGEZI LOTEE M1P M~E NADUK NAO NXXTH OK1 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT UKHRP AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 AARCD 5PM |
| ID | FETCH-LOGICAL-c470t-42c82eb347bd5c3f4c135f0e89bfbb95ce8052f554d555e6c22194363e3a9ab3 |
| IEDL.DBID | C6C |
| ISSN | 2158-3188 |
| IngestDate | Thu Aug 21 14:11:54 EDT 2025 Thu Aug 07 14:51:13 EDT 2025 Sat Aug 23 12:26:53 EDT 2025 Mon Jul 21 05:42:19 EDT 2025 Tue Jul 01 00:55:09 EDT 2025 Thu Apr 24 22:50:45 EDT 2025 Fri Feb 21 02:39:06 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c470t-42c82eb347bd5c3f4c135f0e89bfbb95ce8052f554d555e6c22194363e3a9ab3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0002-0802-0941 0000-0002-8688-8025 |
| OpenAccessLink | https://www.nature.com/articles/s41398-019-0534-2 |
| PMID | 31439831 |
| PQID | 2278001440 |
| PQPubID | 2041978 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6706374 proquest_miscellaneous_2281104334 proquest_journals_2278001440 pubmed_primary_31439831 crossref_primary_10_1038_s41398_019_0534_2 crossref_citationtrail_10_1038_s41398_019_0534_2 springer_journals_10_1038_s41398_019_0534_2 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-08-22 |
| PublicationDateYYYYMMDD | 2019-08-22 |
| PublicationDate_xml | – month: 08 year: 2019 text: 2019-08-22 day: 22 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: United States |
| PublicationTitle | Translational psychiatry |
| PublicationTitleAbbrev | Transl Psychiatry |
| PublicationTitleAlternate | Transl Psychiatry |
| PublicationYear | 2019 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Winton-Brown (CR14) 2017; 7 Fornito (CR23) 2008; 64 Kapur (CR1) 2003; 160 Boggs (CR35) 2018; 235 Yung (CR37) 2005; 39 Schmidt (CR11) 2017; 47 Nielsen (CR17) 2012; 71 Modinos, Allen, Grace, McGuire (CR6) 2015; 38 Laprairie, Bagher, Kelly, Denovan‐Wright (CR48) 2015; 172 CR30 Ceccarini (CR51) 2013; 79 Schott (CR39) 2008; 28 Wotruba (CR26) 2014; 40 Knutson, Westdorp, Kaiser, Hommer (CR38) 2000; 12 Allen (CR7) 2015; 173 Winton-Brown, Fusar-Poli, Ungless, Howes (CR5) 2014; 37 Roiser, Howes, Chaddock, Joyce, McGuire (CR13) 2012; 39 Wilson, Colizzi, Bossong, Allen, Kempton, Bhattacharyya (CR40) 2018; 28 Nielsen (CR41) 2012; 69 Englund (CR32) 2013; 27 Baiano (CR20) 2007; 93 Radua (CR16) 2015; 72 Sridharan, Levitin, Menon (CR44) 2008; 105 Radua (CR47) 2012; 36 Bhattacharyya (CR31) 2010; 35 Seeley (CR18) 2007; 27 Schobel Scott (CR8) 2013; 78 McGuire (CR34) 2018; 175 Wang (CR25) 2016; 46 Uddin (CR19) 2015; 16 Schultz (CR9) 2016; 17 Takahashi (CR27) 2009; 108 Howes (CR2) 2012; 69 Howes (CR4) 2011; 168 Wotruba (CR15) 2014; 8 Menon, Uddin (CR45) 2010; 214 Smieskova (CR12) 2015; 166 Shepherd, Matheson, Laurens, Carr, Green (CR21) 2012; 72 Bhattacharyya (CR36) 2018; 75 Egerton (CR3) 2013; 74 Juckel (CR42) 2012; 66 CR29 Bisogno (CR49) 2001; 134 Strauss, Waltz, Gold (CR10) 2014; 40 CR22 Walter (CR28) 2016; 7 Leweke (CR33) 2012; 2 Mir (CR43) 2011; 209 Ranganathan (CR50) 2016; 79 Takahashi (CR24) 2009; 111 Raij, Mantyla, Mantere, Kieseppa, Suvisaari (CR46) 2016; 46 T Winton-Brown (534_CR14) 2017; 7 R Smieskova (534_CR12) 2015; 166 C Wang (534_CR25) 2016; 46 JP Roiser (534_CR13) 2012; 39 TT Raij (534_CR46) 2016; 46 G Modinos (534_CR6) 2015; 38 B Knutson (534_CR38) 2000; 12 Robin Paul Wilson (534_CR40) 2018; 28 R Laprairie (534_CR48) 2015; 172 S Kapur (534_CR1) 2003; 160 MO Nielsen (534_CR41) 2012; 69 LQ Uddin (534_CR19) 2015; 16 A Englund (534_CR32) 2013; 27 A Walter (534_CR28) 2016; 7 V Menon (534_CR45) 2010; 214 J Ceccarini (534_CR51) 2013; 79 D Sridharan (534_CR44) 2008; 105 534_CR22 534_CR29 MØ Nielsen (534_CR17) 2012; 71 WW Seeley (534_CR18) 2007; 27 A Schmidt (534_CR11) 2017; 47 J Radua (534_CR47) 2012; 36 D Wotruba (534_CR15) 2014; 8 P Allen (534_CR7) 2015; 173 M Baiano (534_CR20) 2007; 93 J Radua (534_CR16) 2015; 72 534_CR30 A Schobel Scott (534_CR8) 2013; 78 OD Howes (534_CR2) 2012; 69 S Bhattacharyya (534_CR31) 2010; 35 M Ranganathan (534_CR50) 2016; 79 BH Schott (534_CR39) 2008; 28 A Egerton (534_CR3) 2013; 74 T Bisogno (534_CR49) 2001; 134 AM Shepherd (534_CR21) 2012; 72 T Takahashi (534_CR24) 2009; 111 D Wotruba (534_CR26) 2014; 40 FM Leweke (534_CR33) 2012; 2 A Fornito (534_CR23) 2008; 64 G Juckel (534_CR42) 2012; 66 S Bhattacharyya (534_CR36) 2018; 75 P Mir (534_CR43) 2011; 209 OD Howes (534_CR4) 2011; 168 TT Winton-Brown (534_CR5) 2014; 37 DL Boggs (534_CR35) 2018; 235 GP Strauss (534_CR10) 2014; 40 P McGuire (534_CR34) 2018; 175 AR Yung (534_CR37) 2005; 39 T Takahashi (534_CR27) 2009; 108 W Schultz (534_CR9) 2016; 17 |
| References_xml | – ident: CR22 – volume: 209 start-page: 551 year: 2011 end-page: 559 ident: CR43 article-title: Motivation and movement: the effect of monetary incentive on performance speed publication-title: Exp. Brain Res. doi: 10.1007/s00221-011-2583-5 – volume: 40 start-page: 1095 year: 2014 end-page: 1104 ident: CR26 article-title: Aberrant coupling within and across the default mode, task-positive, and salience network in subjects at risk for psychosis publication-title: Schizophr. Bull. doi: 10.1093/schbul/sbt161 – volume: 79 start-page: 304 year: 2013 end-page: 312 ident: CR51 article-title: Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia publication-title: NeuroImage doi: 10.1016/j.neuroimage.2013.04.052 – volume: 27 start-page: 19 year: 2013 end-page: 27 ident: CR32 article-title: Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment publication-title: J. Psychopharmacol. doi: 10.1177/0269881112460109 – volume: 46 start-page: 2741 year: 2016 end-page: 2748 ident: CR46 article-title: Cortical salience network activation precedes the development of delusion severity publication-title: Psychol. Med. doi: 10.1017/S0033291716001057 – volume: 38 start-page: 129 year: 2015 end-page: 138 ident: CR6 article-title: Translating the MAM model of psychosis to humans publication-title: Trends Neurosci. doi: 10.1016/j.tins.2014.12.005 – volume: 16 start-page: 55 year: 2015 ident: CR19 article-title: Salience processing and insular cortical function and dysfunction publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn3857 – volume: 175 start-page: 225 year: 2018 end-page: 231 ident: CR34 article-title: Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.2017.17030325 – ident: CR29 – volume: 35 start-page: 764 year: 2010 end-page: 774 ident: CR31 article-title: Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology publication-title: Neuropsychopharmacology doi: 10.1038/npp.2009.184 – volume: 78 start-page: 81 year: 2013 end-page: 93 ident: CR8 article-title: Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver publication-title: Neuron. doi: 10.1016/j.neuron.2013.02.011 – volume: 105 start-page: 12569 year: 2008 end-page: 12574 ident: CR44 article-title: A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0800005105 – volume: 172 start-page: 4790 year: 2015 end-page: 4805 ident: CR48 article-title: Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor publication-title: Br. J. Pharmacol. doi: 10.1111/bph.13250 – volume: 168 start-page: 1311 year: 2011 end-page: 1317 ident: CR4 article-title: Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.2011.11010160 – volume: 64 start-page: 758 year: 2008 end-page: 765 ident: CR23 article-title: Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2008.05.032 – volume: 111 start-page: 94 year: 2009 end-page: 102 ident: CR24 article-title: Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis publication-title: Schizophr. Res. doi: 10.1016/j.schres.2009.03.024 – volume: 79 start-page: 997 year: 2016 end-page: 1005 ident: CR50 article-title: Reduced brain cannabinoid receptor availability in schizophrenia publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2015.08.021 – volume: 235 start-page: 1923 year: 2018 end-page: 1932 ident: CR35 article-title: The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial publication-title: Psychopharmacology doi: 10.1007/s00213-018-4885-9 – volume: 75 start-page: 1107 year: 2018 end-page: 1117 ident: CR36 article-title: Effect of cannabidiol on medial temporal, midbrain, and striatal dysfunction in people at clinical high risk of psychosis: a randomized clinical trial publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2018.2309 – volume: 39 start-page: 964 year: 2005 end-page: 971 ident: CR37 article-title: Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states publication-title: Aust. N. Z. J. Psychiatry doi: 10.1080/j.1440-1614.2005.01714.x – volume: 28 start-page: 496 issue: 4 year: 2018 end-page: 506 ident: CR40 article-title: The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task publication-title: Neuropsychology Review doi: 10.1007/s11065-018-9385-5 – volume: 40 start-page: S107 year: 2014 end-page: S116 ident: CR10 article-title: A review of reward processing and motivational impairment in schizophrenia publication-title: Schizophr. Bull. doi: 10.1093/schbul/sbt197 – volume: 108 start-page: 49 year: 2009 end-page: 56 ident: CR27 article-title: Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia publication-title: Schizophr. Res. doi: 10.1016/j.schres.2008.12.029 – volume: 214 start-page: 655 year: 2010 end-page: 667 ident: CR45 article-title: Saliency, switching, attention and control: a network model of insula function publication-title: Brain Struct. Funct. doi: 10.1007/s00429-010-0262-0 – volume: 28 start-page: 14311 year: 2008 end-page: 14319 ident: CR39 article-title: Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2058-08.2008 – volume: 66 start-page: 50 year: 2012 end-page: 56 ident: CR42 article-title: Ventral striatal activation during reward processing in subjects with ultra-high risk for schizophrenia publication-title: Neuropsychobiology doi: 10.1159/000337130 – volume: 7 start-page: 189 year: 2016 ident: CR28 article-title: Altered insular function during aberrant salience processing in relation to the severity of psychotic symptoms publication-title: Front Psychiatry doi: 10.3389/fpsyt.2016.00189 – volume: 71 start-page: 898 year: 2012 end-page: 905 ident: CR17 article-title: Alterations of the brain reward system in antipsychotic naïve schizophrenia patients publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2012.02.007 – volume: 93 start-page: 1 year: 2007 end-page: 12 ident: CR20 article-title: Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies publication-title: Schizophr. Res. doi: 10.1016/j.schres.2007.02.012 – volume: 46 start-page: 2771 year: 2016 end-page: 2783 ident: CR25 article-title: Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study publication-title: Psychol. Med. doi: 10.1017/S0033291716001410 – volume: 7 year: 2017 ident: CR14 article-title: Altered activation and connectivity in a hippocampal-basal ganglia-midbrain circuit during salience processing in subjects at ultra high risk for psychosis publication-title: Transl. Psychiatry doi: 10.1038/tp.2017.174 – volume: 37 start-page: 85 year: 2014 end-page: 94 ident: CR5 article-title: Dopaminergic basis of salience dysregulation in psychosis publication-title: Trends Neurosci. doi: 10.1016/j.tins.2013.11.003 – volume: 39 start-page: 1328 year: 2012 end-page: 1336 ident: CR13 article-title: Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis publication-title: Schizophr. Bull. doi: 10.1093/schbul/sbs147 – volume: 27 start-page: 2349 year: 2007 end-page: 2356 ident: CR18 article-title: Dissociable intrinsic connectivity networks for salience processing and executive control publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.5587-06.2007 – volume: 166 start-page: 17 year: 2015 end-page: 23 ident: CR12 article-title: Modulation of motivational salience processing during the early stages of psychosis publication-title: Schizophr. Res. doi: 10.1016/j.schres.2015.04.036 – ident: CR30 – volume: 2 year: 2012 ident: CR33 article-title: Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia publication-title: Transl. Psychiatry doi: 10.1038/tp.2012.15 – volume: 12 start-page: 20 year: 2000 end-page: 27 ident: CR38 article-title: FMRI visualization of brain activity during a monetary incentive delay task publication-title: Neuroimage doi: 10.1006/nimg.2000.0593 – volume: 69 start-page: 776 year: 2012 end-page: 786 ident: CR2 article-title: The nature of dopamine dysfunction in schizophrenia and what this means for treatment publication-title: Arch. Gen. Psychiatry doi: 10.1001/archgenpsychiatry.2012.169 – volume: 173 start-page: 392 year: 2015 end-page: 399 ident: CR7 article-title: Resting hyperperfusion of the hippocampus, midbrain, and basal ganglia in people at high risk for psychosis publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.2015.15040485 – volume: 47 start-page: 243 year: 2017 end-page: 254 ident: CR11 article-title: Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis publication-title: Psychol. Med. doi: 10.1017/S0033291716002439 – volume: 134 start-page: 845 year: 2001 end-page: 852 ident: CR49 article-title: Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0704327 – volume: 69 start-page: 1195 year: 2012 end-page: 1204 ident: CR41 article-title: Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia publication-title: Arch. Gen. Psychiatry doi: 10.1001/archgenpsychiatry.2012.847 – volume: 17 start-page: 183 year: 2016 end-page: 195 ident: CR9 article-title: Dopamine reward prediction-error signalling: a two-component response publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn.2015.26 – volume: 36 start-page: 2325 year: 2012 end-page: 2333 ident: CR47 article-title: Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication publication-title: Neurosci. Biobehav. Rev. doi: 10.1016/j.neubiorev.2012.07.012 – volume: 72 start-page: 1243 year: 2015 end-page: 1251 ident: CR16 article-title: Ventral striatal activation during reward processing in psychosis: a neurofunctional meta-analysis publication-title: JAMA psychiatry doi: 10.1001/jamapsychiatry.2015.2196 – volume: 74 start-page: 106 year: 2013 end-page: 112 ident: CR3 article-title: Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2012.11.017 – volume: 72 start-page: 775 year: 2012 end-page: 784 ident: CR21 article-title: Systematic meta-analysis of insula volume in schizophrenia publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2012.04.020 – volume: 8 start-page: 382 year: 2014 ident: CR15 article-title: Symptom dimensions are associated with reward processing in unmedicated persons at risk for psychosis publication-title: Front Behav. Neurosci. doi: 10.3389/fnbeh.2014.00382 – volume: 160 start-page: 13 year: 2003 end-page: 23 ident: CR1 article-title: Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.160.1.13 – volume: 72 start-page: 1243 year: 2015 ident: 534_CR16 publication-title: JAMA psychiatry doi: 10.1001/jamapsychiatry.2015.2196 – volume: 93 start-page: 1 year: 2007 ident: 534_CR20 publication-title: Schizophr. Res. doi: 10.1016/j.schres.2007.02.012 – volume: 12 start-page: 20 year: 2000 ident: 534_CR38 publication-title: Neuroimage doi: 10.1006/nimg.2000.0593 – volume: 16 start-page: 55 year: 2015 ident: 534_CR19 publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn3857 – volume: 37 start-page: 85 year: 2014 ident: 534_CR5 publication-title: Trends Neurosci. doi: 10.1016/j.tins.2013.11.003 – ident: 534_CR22 doi: 10.1093/schbul/sby094 – volume: 175 start-page: 225 year: 2018 ident: 534_CR34 publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.2017.17030325 – volume: 40 start-page: S107 year: 2014 ident: 534_CR10 publication-title: Schizophr. Bull. doi: 10.1093/schbul/sbt197 – volume: 173 start-page: 392 year: 2015 ident: 534_CR7 publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.2015.15040485 – volume: 108 start-page: 49 year: 2009 ident: 534_CR27 publication-title: Schizophr. Res. doi: 10.1016/j.schres.2008.12.029 – volume: 64 start-page: 758 year: 2008 ident: 534_CR23 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2008.05.032 – volume: 27 start-page: 19 year: 2013 ident: 534_CR32 publication-title: J. Psychopharmacol. doi: 10.1177/0269881112460109 – volume: 17 start-page: 183 year: 2016 ident: 534_CR9 publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn.2015.26 – volume: 39 start-page: 1328 year: 2012 ident: 534_CR13 publication-title: Schizophr. Bull. doi: 10.1093/schbul/sbs147 – volume: 47 start-page: 243 year: 2017 ident: 534_CR11 publication-title: Psychol. Med. doi: 10.1017/S0033291716002439 – volume: 8 start-page: 382 year: 2014 ident: 534_CR15 publication-title: Front Behav. Neurosci. doi: 10.3389/fnbeh.2014.00382 – volume: 28 start-page: 14311 year: 2008 ident: 534_CR39 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2058-08.2008 – volume: 75 start-page: 1107 year: 2018 ident: 534_CR36 publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2018.2309 – volume: 209 start-page: 551 year: 2011 ident: 534_CR43 publication-title: Exp. Brain Res. doi: 10.1007/s00221-011-2583-5 – volume: 69 start-page: 776 year: 2012 ident: 534_CR2 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archgenpsychiatry.2012.169 – volume: 27 start-page: 2349 year: 2007 ident: 534_CR18 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.5587-06.2007 – volume: 66 start-page: 50 year: 2012 ident: 534_CR42 publication-title: Neuropsychobiology doi: 10.1159/000337130 – ident: 534_CR29 doi: 10.1016/j.psym.2018.03.006 – volume: 2 year: 2012 ident: 534_CR33 publication-title: Transl. Psychiatry doi: 10.1038/tp.2012.15 – volume: 78 start-page: 81 year: 2013 ident: 534_CR8 publication-title: Neuron. doi: 10.1016/j.neuron.2013.02.011 – volume: 7 year: 2017 ident: 534_CR14 publication-title: Transl. Psychiatry doi: 10.1038/tp.2017.174 – volume: 35 start-page: 764 year: 2010 ident: 534_CR31 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2009.184 – volume: 46 start-page: 2741 year: 2016 ident: 534_CR46 publication-title: Psychol. Med. doi: 10.1017/S0033291716001057 – volume: 168 start-page: 1311 year: 2011 ident: 534_CR4 publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.2011.11010160 – volume: 160 start-page: 13 year: 2003 ident: 534_CR1 publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.160.1.13 – volume: 46 start-page: 2771 year: 2016 ident: 534_CR25 publication-title: Psychol. Med. doi: 10.1017/S0033291716001410 – volume: 71 start-page: 898 year: 2012 ident: 534_CR17 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2012.02.007 – volume: 79 start-page: 304 year: 2013 ident: 534_CR51 publication-title: NeuroImage doi: 10.1016/j.neuroimage.2013.04.052 – volume: 7 start-page: 189 year: 2016 ident: 534_CR28 publication-title: Front Psychiatry doi: 10.3389/fpsyt.2016.00189 – volume: 69 start-page: 1195 year: 2012 ident: 534_CR41 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archgenpsychiatry.2012.847 – volume: 38 start-page: 129 year: 2015 ident: 534_CR6 publication-title: Trends Neurosci. doi: 10.1016/j.tins.2014.12.005 – volume: 79 start-page: 997 year: 2016 ident: 534_CR50 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2015.08.021 – volume: 214 start-page: 655 year: 2010 ident: 534_CR45 publication-title: Brain Struct. Funct. doi: 10.1007/s00429-010-0262-0 – volume: 74 start-page: 106 year: 2013 ident: 534_CR3 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2012.11.017 – volume: 166 start-page: 17 year: 2015 ident: 534_CR12 publication-title: Schizophr. Res. doi: 10.1016/j.schres.2015.04.036 – volume: 134 start-page: 845 year: 2001 ident: 534_CR49 publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0704327 – volume: 111 start-page: 94 year: 2009 ident: 534_CR24 publication-title: Schizophr. Res. doi: 10.1016/j.schres.2009.03.024 – volume: 235 start-page: 1923 year: 2018 ident: 534_CR35 publication-title: Psychopharmacology doi: 10.1007/s00213-018-4885-9 – volume: 39 start-page: 964 year: 2005 ident: 534_CR37 publication-title: Aust. N. Z. J. Psychiatry doi: 10.1080/j.1440-1614.2005.01714.x – volume: 72 start-page: 775 year: 2012 ident: 534_CR21 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2012.04.020 – volume: 40 start-page: 1095 year: 2014 ident: 534_CR26 publication-title: Schizophr. Bull. doi: 10.1093/schbul/sbt161 – volume: 28 start-page: 496 issue: 4 year: 2018 ident: 534_CR40 publication-title: Neuropsychology Review doi: 10.1007/s11065-018-9385-5 – volume: 105 start-page: 12569 year: 2008 ident: 534_CR44 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0800005105 – volume: 172 start-page: 4790 year: 2015 ident: 534_CR48 publication-title: Br. J. Pharmacol. doi: 10.1111/bph.13250 – ident: 534_CR30 doi: 10.1503/jpn.100176 – volume: 36 start-page: 2325 year: 2012 ident: 534_CR47 publication-title: Neurosci. Biobehav. Rev. doi: 10.1016/j.neubiorev.2012.07.012 |
| SSID | ssj0000548171 |
| Score | 2.4144788 |
| Snippet | Accumulating evidence points towards the antipsychotic potential of cannabidiol. However, the neurocognitive mechanisms underlying the antipsychotic effect of... |
| SourceID | pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 203 |
| SubjectTerms | 59/36 631/154/436/2388 692/699/476/1799 Adolescent Adult Behavioral Sciences Biological Psychology Brain Mapping Cannabidiol - pharmacology Cerebral Cortex - diagnostic imaging Cerebral Cortex - drug effects Double-Blind Method Female Humans Magnetic Resonance Imaging Male Medicine Medicine & Public Health Motivation - drug effects Neurosciences Pharmacotherapy Psychiatry Psychosis Psychotic Disorders - diagnostic imaging Psychotic Disorders - psychology Psychotropic drugs Reaction Time - drug effects Young Adult |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT-MwELaAlRCX1e7yKrDISJxAEYkfcXJaIQRCSHACqbfIdhwRCdxSt4e98suZyQsVBOe4bpJvPP7imfmGkGOUADGJM5HB1EZhFI80B0BsHlunHKBeYYHz7V16_SBuxnLcHbiFLq2y94mNoy4nFs_Iz7BkE_m8iP9NXyLsGoXR1a6Fxir5gdJlmNKlxmo4YwE6kiUq6YOZPDsL4LOxpgwrdyQXEVvejj5xzM-pkh_ipc02dPWL_Oz4Iz1vAf9NVpz_Q9Zvuwj5Jnm90N5rU5f15ImidqZfIJukTc65ntHyf8CtDOGgbYkifR5anMHEAXg5LnY6bSsIcEDtaVgYPLAJMCXtiykpSh1TzE2nwHxpW88V6rBF7q8u7y-uo67PQmSFiueRYDZj8FEtlCml5ZWwCZdV7LLcVMbk0jrse1AB8SillC61DNyc4Cl3XOfa8G2y5ife7RIKH0-lNDq2zDiRopJ9WTItAIYcnFkiRiTu33ZhOw1ybIXxVDSxcJ4VLUAFAFQgQAUbkZPhJ9NWgOO7wQc9hEW3FkPxbjkjcjRchlWEoRHt3WSBYzLgQYJzuMWdFvHh3zhQyjzjyYioJVsYBqBC9_IVXz82St2pAgaoYM7T3mreb-vLh9j7_iH2yQZr7Bc8HDsga_PZwv0FYjQ3h431vwHndA46 priority: 102 providerName: ProQuest |
| Title | Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis |
| URI | https://link.springer.com/article/10.1038/s41398-019-0534-2 https://www.ncbi.nlm.nih.gov/pubmed/31439831 https://www.proquest.com/docview/2278001440 https://www.proquest.com/docview/2281104334 https://pubmed.ncbi.nlm.nih.gov/PMC6706374 |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7SBEovJelz81hU6KnF1LYkyz5ul4SwkFDaFPZmJFmmhkQb4t1Dr_3lmZEfZbu00NMePNZqd6TRJ818nwDekwSISZyJDJU2CqN4pDk6xBaxdcqh12siOF9dZ5ffxWIpl3uQDFyYULQfJC1DmB6qwz61GGyJDEaUG8lFhFH3gJTbaVDPs_l4rIIIJE9UMuQveb775vYKtAMrd6sj_0iRhpXn4hCe95CRzbpOHsGe8y_g6VWfFH8Jv-bae22aqlndMpLL9BsCkCyUmesHVv1safUiD7COlcjuxlvNsOEWoTjNb3bfkQbIoPGs3Rg6o2mxSTbwJxmpGzMqR2cIdllH4Wqb9hXcXJzfzC-j_mqFyAoVryOR2jzFfbRQppKW18ImXNaxywtTG1NI6-iqgxqxRiWldJlNMbIJnnHHdaENfw37fuXdW2C4X6qk0bFNjRMZiddXVaoFuqHA-JWICcTDv13aXnacbr-4LUP6m-dl56ASHVSSg8p0Ah_GV-47zY1_GZ8OLiz76deWxO-lzZ-IJ_BufIwTh7Ih2rvVhmxyhD6Cc-zim87j47dxRJFFzpMJqK2xMBqQKPf2E9_8COLcmULQp7DNj8Oo-d2tv_6I4_-yPoFnaRjOGOPSU9hfP2zcGUKjtZnCE7VUUziYzRbfFvj5-fz6y9dpmCLTcNzwCITGELg |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VVgIuiGdZKGAkuICiJrbzOiAEpdWWdlcILVJvlu04IlLxLs2uUK_8H_4jM3lVS0VvvSZeJ9lvZvzZ8wJ4RSVATORMYCi0UZpUBFogIDYPrUsdol5SgvNkmoy_yc8n8ckG_OlzYSissreJjaEu5pbOyHcpZZP4vAzfL34G1DWKvKt9C41WLI7c-S_cstXvDj8hvq85P9if7Y2DrqtAYGUaLgPJbcZxCylTU8RWlNJGIi5Dl-WmNCaPraMq_yUus0Ucxy6xHJVaikQ4oXNtBE57A7bwQoh2YOvj_vTL1-FQB_lPFqVR7z0V2W6NiwQlsVGqUCxkwNfXv0uk9nJs5j8O2mbdO7gLdzrCyj60EnYPNpy_DzcnnUv-Afze095rUxXV_JRRsU6_IvrKmiB3fcaK85rWTsKftTmR7MfQUw0nrnEjQNaFLdqUBRpQeVavDJ0Q1Tgl67M3GdVWZhQMz5BqszaBrK7qhzC7Dggewaafe_cYGO7Witjo0HLjZEKl84uCa4kw5Gg9IzmCsP-3le2KnlPvjVPVON9FplqAFAKkCCDFR_Bm-Mmirfhx1eCdHkLVKX-tLkR1BC-H26i25IvR3s1XNCZD4iWFwFfcbhEfniaQw-aZiEaQrsnCMIBKgq_f8dX3pjR4kiLlTHHOt73UXLzWfz_iydUf8QJujWeTY3V8OD16Crd5I8toXvkObC7PVu4ZsrKled7pAgN1zdr3F5t8S9k |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcUMtz2wJGggso2sSPODkgVLWsWkorDkXamxU7jhqpZJdmV1Wv_Cv-HTN5VUtFbz3HcR7fzPiz5wXwjkqA2MjbwFJoo7RaBJlAQFwaOq89ol5QgvPJaXz4Q36dquka_OlzYSissreJjaHOZ47OyMeUskl8XobjoguL-H4w-Tz_FVAHKfK09u00WhE59tdXuH2rPx0dINbvOZ98Ods_DLoOA4GTOlwEkruE43ZSapsrJwrpIqGK0CepLaxNlfNU8b_AJTdXSvnYcVRwKWLhRZZmVuC0D-ChFioiFdNTPRzvIBNKIh31flSRjGtcLiidjZKGlJABX10Jb9Hb21Ga_7hqmxVwsgmPO-rK9lpZ24I1Xz2BjZPOOf8Ufu9nVZXZMi9nF4zKdlZLIrKsCXfPLll-XdMqSpLA2uxI9nPoroYT17glIDvD5m3yAg0oK1YvLZ0V1Tgl6_M4GVVZZhQWz5B0szaVrC7rZ3B2HwA8h_VqVvmXwHDfliubhY5bL2Mqop_nPJMIQ4p2NJIjCPu_bVxX_py6cFyYxg0vEtMCZBAgQwAZPoIPwy3ztvbHXYN3ewhNZwZqcyO0I3g7XEYFJq9MVvnZksYkSMGkEPiKL1rEh6cJZLNpIqIR6BVZGAZQcfDVK1V53hQJjzWST41zfuyl5ua1_vsR23d_xBvYQJ0z345Oj3fgEW9EGe0s34X1xeXSv0J6trCvG0VgYO5Z8f4CR7JOqQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cannabidiol+attenuates+insular+dysfunction+during+motivational+salience+processing+in+subjects+at+clinical+high+risk+for+psychosis&rft.jtitle=Translational+psychiatry&rft.au=Wilson%2C+Robin&rft.au=Bossong%2C+Matthijs+G.&rft.au=Appiah-Kusi%2C+Elizabeth&rft.au=Petros%2C+Natalia&rft.date=2019-08-22&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2158-3188&rft.volume=9&rft_id=info:doi/10.1038%2Fs41398-019-0534-2&rft_id=info%3Apmid%2F31439831&rft.externalDocID=PMC6706374 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2158-3188&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2158-3188&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2158-3188&client=summon |